Ozempic Dual Dose (Semaglutide PFS) 2mg/ 1.5ml

Semaglutide, the active ingredient in Ozempic Dual Dose, works by acting as an agonist of the glucagon-like peptide-1 (GLP-1) receptor. This enhances glucose-dependent insulin secretion, suppresses glucagon release, and slows gastric emptying. These actions help to lower blood sugar levels and improve glycemic control in patients with type 2 diabetes.

The usual dose of Ozempic Dual Dose is determined by a healthcare provider based on the patient's individual needs and response to treatment. The initial dose is typically 0.25 mg once weekly, which may be increased to 0.5 mg, 1 mg, or 2 mg once weekly as needed.

Ozempic Dual Dose should be avoided during pregnancy and for at least two months after treatment. It should also be avoided during breastfeeding. Always consult with a healthcare provider for personalized advice.

To order Ozempic Dual Dose from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets and will ask the buyer to confirm trade or institutional credentials. The team will then reply with pricing, availability, shipping, and the import paperwork.

Ozempic Dual Dose is a GLP-1 receptor agonist, which works differently from other classes of antidiabetic medications such as metformin or sulfonylureas. It is particularly effective in improving glycemic control and may also aid in weight management. The choice of medication depends on individual patient needs and should be discussed with a healthcare provider.

Ozempic Dual Dose should be stored at 2-8°C, kept refrigerated, protected from light, and not frozen or shaken. Always follow the storage instructions provided with the medication to ensure its effectiveness and safety.

Ozempic Dual Dose is administered via subcutaneous injection, typically once weekly. The pre-filled syringe makes it convenient to use. Always follow the administration instructions provided by your healthcare provider.

The most serious risks associated with Ozempic Dual Dose include pancreatitis, hypoglycemia (when used with other antidiabetic agents), kidney problems, allergic reactions, changes in vision, and gallbladder problems. Always consult with a healthcare provider if you experience any severe or persistent side effects.

Ozempic Dual Dose should not be used by individuals with a personal history of pancreatitis, severe kidney problems, or allergic reactions to semaglutide or any of its components. It should also be avoided during pregnancy and breastfeeding. Always consult with a healthcare provider to determine if Ozempic Dual Dose is suitable for you.